Defosfamide

This classification denotes a nitrogen mustard compound with the molecular formula C9H20Cl3N2O3P, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 0W33021S30, chemically known as phosphorodiamidic acid, n,n-bis(2-chloroethyl)-n-(3-hydroxypropyl)-, (2-chloroethyl) ester but more generally known as defosfamide, which bears US NIH Compound Identifier 71164. European Medicines Agency schedules Defosfamide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06944MIG. The term DEFOSFAMIDE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 19 1975, List 5). DEFOSFAMIDE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule defosfamide under HS 29299000 and SITC 51489. As of Q4 2014, DEFOSFAMIDE remains US FDA's Preferred Term for this commodity. Defosfamide bears US NLM identifiers UMLS ID C1511757 and NCI Concept Code C2069. SMILES: CLCCN(P(=O)(OCCCL)NCCCO)CCCL.